While wild-type p53 and LATS2 cooperate in inhibiting SREBP expression, mutp53 has been shown to sustain the expression of SREBP in breast cancer cells, suggesting an additional layer of positive regulation of YAP by mutp53, through the upregulation of lipid metabolism [156]. Here, YAP1 is linked to breast cancer.